These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29544975)

  • 1. [Pharmacokinetic risk factors of beta-blockers overdose in the elderly: Case report and pharmacology approach].
    Lafarge L; Bourguignon L; Bernard N; Vial T; Dehan-Moya MJ; De La Gastine B; Goutelle S
    Ann Cardiol Angeiol (Paris); 2018 Apr; 67(2):91-97. PubMed ID: 29544975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of bisoprolol and its effect on dialysis refractory hypertension.
    Kanegae K; Hiroshige K; Suda T; Iwamoto M; Ohta T; Nakashima Y; Ohtani A
    Int J Artif Organs; 1999 Dec; 22(12):798-804. PubMed ID: 10654875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor tolerance of beta-blockers by elderly patients with heart failure.
    Yanagisawa S; Suzuki N; Tanaka T
    Clin Interv Aging; 2010 Nov; 5():365-8. PubMed ID: 21152238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The choked heart].
    Furrer F; Giambarba C
    Praxis (Bern 1994); 2012 Jul; 101(14):919-22. PubMed ID: 22763935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
    Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated intensification of lower urinary tract symptoms in the patient with benign prostatic hyperplasia during bisoprolol treatment.
    Sein Anand J; Chodorowski Z; Hajduk A
    Przegl Lek; 2005; 62(6):522-3. PubMed ID: 16225113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpectedly high blood concentration of bisoprolol after an incorrect prescription: A case report.
    Hashiyada M; Usui K; Hayashizaki Y; Hosoya T; Igari Y; Sakai J; Funayama M
    Leg Med (Tokyo); 2013 Mar; 15(2):103-5. PubMed ID: 23219584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Every 2nd heart failure patient without beta blocker. "Intolerance" is often a dosage error].
    MMW Fortschr Med; 2003 Feb; 145(6):58. PubMed ID: 12619366
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-drug interactions of beta-adrenoceptor blockers.
    Brodde OE; Kroemer HK
    Arzneimittelforschung; 2003; 53(12):814-22. PubMed ID: 14732961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta-blockers and non-cardiac surgery: benefit and risks].
    Schaal JV; Pelée de Saint Maurice G; Boutonnet M; Cottez-Gacia S; Ausset S
    Ann Fr Anesth Reanim; 2009 Sep; 28(9):806-7; author reply 807-8. PubMed ID: 19651484
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
    Ko DT; Hebert PR; Coffey CS; Curtis JP; Foody JM; Sedrakyan A; Krumholz HM
    Arch Intern Med; 2004 Jul; 164(13):1389-94. PubMed ID: 15249347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome].
    Tomcsányi J; Jávor K; Arabadzisz H; Zsoldos A; Wagner V; Sármán B
    Orv Hetil; 2013 Feb; 154(7):267-71. PubMed ID: 23395791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Bisoprolol on the Level of Dabigatran.
    Nehaj F; Sokol J; Ivankova J; Mokan M; Mokan M
    Am J Ther; 2020; 27(2):e159-e164. PubMed ID: 30074534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of a cardioselective beta1-adrenoblocker bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic heart disease].
    Tsvetkova OA; Veselovskaia MV
    Ter Arkh; 2007; 79(3):25-9. PubMed ID: 17526191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alternating dosage of bisoprolol?].
    Wehling M
    Internist (Berl); 1998 Mar; 39(3):316. PubMed ID: 9561455
    [No Abstract]   [Full Text] [Related]  

  • 17. BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure.
    Miró Ò; Müller C; Martín-Sánchez FJ; Bueno H; Mebazaa A; Herrero P; Jacob J; Gil V; Escoda R; Llorens P;
    Clin Res Cardiol; 2016 Dec; 105(12):1021-1029. PubMed ID: 27379611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.
    Galatius S; Gustafsson F; Atar D; Hildebrandt PR
    Cardiology; 2004; 102(3):160-5. PubMed ID: 15334027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness and tolerability of bisoprolol vs. nifedipine in uremic patients with ischemic cardiopathy in dialysis treatment].
    Cice G; Di Benedetto A; Tagliamonte E; Ferrara L; Sorice P; Iacono A
    Cardiologia; 1997 Apr; 42(4):397-403. PubMed ID: 9244644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisoprolol: a review of its use in chronic heart failure.
    McGavin JK; Keating GM
    Drugs; 2002; 62(18):2677-96. PubMed ID: 12466013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.